All In Biotech

Drug Trial Radar · NCT06021054

An Efficacy, Safety, and Tolerability Study of Veligrotug (VRDN-001), in Participants With Chronic Thyroid Eye Disease (TED)

A Randomized, Double-masked, Placebo-controlled Safety, Tolerability, and Efficacy Study of VRDN-001, a Humanized Monoclonal Antibody Directed Against the IGF-1 Receptor, in Participants With Chronic Thyroid Eye Disease (TED)

Last checked: Nov 20, 2026Latest source record: Aug 13, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. Randomized with 188 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

188

Actual

Start

Nov 1, 2023

Primary completion

Nov 4, 2024

Study completion Jul 25, 2025

Sponsor

Lead sponsor
Viridian Therapeutics, Inc.Industry
Sponsor type
Industry
First posted
Sep 1, 2023

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Triple (participant, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 75 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a clinical trial assessing the efficacy, safety, and tolerability of an investigational drug, veligrotug (VRDN-001), in participants with chronic thyroid eye disease (TED).

Conditions

  • Thyroid Eye Disease

Interventions

  • VeligrotugDrug

    5 IV Infusions of veligrotug 10 mg/kg

  • PlaceboDrug

    5 IV Infusions of veligrotug matched placebo

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Proptosis Responder Rate (PRR) in the Most Proptotic Eye as Measured by ExophthalmometerTime frame: Baseline to Week 15

Locations

57 sites in 9 countries. Site status is shown where the registry gives one.

  • Advancing Research International, LLC

    Los Angeles, California

  • USC Roski Eye Institute

    Los Angeles, California

  • Amy Patel Jain, MD

    Newport Beach, California

  • Stanford Byers Eye Institute

    Palo Alto, California

  • Cockerham Eye Consultants, PC

    San Diego, California

  • Bascom Palmer Eye Institute - Ophthalmology - Miami

    Miami, Florida

  • Sarasota Retina Institute

    Sarasota, Florida

  • Northwestern University

    Chicago, Illinois

  • Family Eye Physicians, Ltd

    Oak Lawn, Illinois

  • Massachusetts Eye and Ear

    Boston, Massachusetts

  • Ophthalmic Consultants of Boston

    Boston, Massachusetts

  • Michigan State University, Department of Neurology

    East Lansing, Michigan

  • Kahana Oculoplastic and Orbital Surgery

    Livonia, Michigan

  • Washington University School of Medicine in St Louis - Ophthalmology

    St Louis, Missouri

  • Steven Leibowitz, MD.

    Las Vegas, Nevada

  • Rutgers - New Jersey Medical School

    Newark, New Jersey

  • The Center for Eye and Facial Plastic Surgery

    Somerset, New Jersey

  • Department of Ophthalmology, University of Pennsylvania

    Philadelphia, Pennsylvania

  • Wills Eye Hospital

    Philadelphia, Pennsylvania

  • Baylor College of Medicine (BCM) - Ophthalmology

    Houston, Texas

  • Neuro Eye Clinical Trials

    Houston, Texas

  • University of Vermont Medical Center

    Burlington, Vermont

  • Harborview Medical Center

    Seattle, Washington

  • North Shore Private Hospital

    Saint Leonards, New South Wales, Australia

  • CHU Angers

    Angers, France

  • CHU de Bordeaux - Hôpital Saint-André

    Bordeaux, France

  • Centre Hospitalier Universitaire De Nantes - G. R. Laennec

    Nantes, France

  • CH Nice

    Nice, France

  • Charité - Universitätsmedizin Berlin KöR

    Berlin, Germany

  • Universitätsklinikum Essen AöR

    Essen, Germany

  • University Medical Center Freiburg

    Freiburg im Breisgau, Germany

  • Universitätsmedizin Göttingen

    Göttingen, Germany

  • Budapest Retina Intezet

    Budapest, Hungary

  • Ganglion Orvosi Kozpont

    Pécs, Hungary

  • Pecsi Tudomanyegyetem Klinikai Kozpont Szemeszeti Klinika

    Pécs, Hungary

  • Uniwersytecki Szpital Kliniczny w Bialymstoku

    Bialystok, Poland

  • Oculomedica Sp. z o.o.

    Bialystok, Poland

  • Optimum Profesorskie Centrum Okulistyki Sp. z o.o.

    Gdansk, Poland

  • Centrum Medyczne Pulawska Sp. z o.o.

    Piaseczno, Poland

  • Centrum Medyczne Piasta 47 sp. z o.o.

    Wałbrzych, Poland

Showing 40 of 57 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.